205923-56-4

URI: https://gptkb.org/entity/205923-56-4

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:chemical_compound
gptkbp:administeredBy	oral
gptkbp:ATCCode	N05CM25
gptkbp:CASNumber	gptkb:205923-56-4
gptkbp:developedBy	gptkb:Merck_&_Co.
gptkbp:eliminationHalfLife	12 hours
gptkbp:excretion	urine feces
gptkbp:hasMolecularFormula	C23H23ClN6O2
gptkbp:hasTherapeuticUse	treatment of insomnia
gptkbp:hasUNII	7X9Q64V895
gptkbp:isApprovedDrug	true
gptkbp:IUPACName	[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone
gptkbp:legalStatus	prescription only
gptkbp:marketedAs	gptkb:Belsomra
gptkbp:mechanismOfAction	gptkb:orexin_receptor_antagonist
gptkbp:metabolism	liver
gptkbp:molecularWeight	450.92 g/mol
gptkbp:name	gptkb:Suvorexant
gptkbp:pregnancyCategory	C (US)
gptkbp:proteinBinding	99%
gptkbp:PubChem_CID	CHEMBL2108507 24964624 DB09025
gptkbp:routeOfAdministration	oral
gptkbp:sideEffect	dizziness headache somnolence abnormal dreams
gptkbp:bfsParent	gptkb:cetuximab gptkb:Erbitux
gptkbp:bfsLayer	7
https://www.w3.org/2000/01/rdf-schema#label	205923-56-4